Shares in Dexcom (DXCM) dropped 9% on Tuesday after the medical device company pre-announced revenue of $500.9M.
DexCom (NASDAQ:DXCM) stock is trading up on news that its medical app system, the DexCom Share system, to be used in conjunction with …
Dexcom’s (NASDAQ: DXCM) G4 Platinum Continuous Glucose Monitoring System received FDA approval yesterday on January 27th. Dexcom develops monitors that detect glucose levels to …
In a research report issued today, William Blair analyst Ben Andrew assigned an Outperform rating on Dexcom (NASDAQ:DXCM). No price target was provided.